Aurinia Pharmaceuticals Inc (AUPH)

[zzaatt]

but ph 3 results are a relative easy hurdle jump over compared to the approval process over the next 6-9 months.

BS!!!

The "idiosyncrasies" of the FDA will not keep a desperately needed drug off the market if the P3 results are good. The real question over the following months is the question of who will buy the company, for how much, and who's going to carry forward the dry eye indication.